Wolverine Trading, LLC Altimmune, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$5.5 - $8.1 $33,000 - $48,600	-6,000 Reduced 7.38%	75,300 $462,000
Q2 2024 Aug 14, 2024	BUY	$5.91 - $10.23 $96,333 - $166,749	16,300 Added 25.08%	81,300 $540,000
Q1 2024 May 15, 2024	SELL	$8.22 - $13.81 $360,858 - $606,259	-43,900 Reduced 40.31%	65,000 $661,000
Q4 2023 Feb 14, 2024	BUY	$2.14 - $11.62 $70,192 - $381,136	32,800 Added 43.1%	108,900 $1.23 Million
Q3 2023 Nov 15, 2023	BUY	$2.4 - $3.45 $69,120 - $99,360	28,800 Added 60.89%	76,100 $197,000
Q2 2023 Aug 23, 2023	SELL	$3.45 - $5.97 $137,310 - $237,606	-39,800 Reduced 45.69%	47,300 $166,000
Q1 2023 May 15, 2023	BUY	$4.19 - $16.83 $13,827 - $55,538	3,300 Added 3.94%	87,100 $368,000
Q4 2022 Feb 14, 2023	BUY	$8.74 - $16.45 $28,842 - $54,285	3,300 Added 4.1%	83,800 $1.38 Million
Q3 2022 Nov 14, 2022	BUY	$10.67 - $22.41 $540,969 - $1.14 Million	50,700 Added 170.13%	80,500 $1.02 Million
Q2 2022 Aug 15, 2022	BUY	$3.94 - $11.77 $117,412 - $350,746	29,800 New	29,800 $351,000
Q1 2022 May 16, 2022	SELL	$5.9 - $9.45 $102,070 - $163,485	-17,300 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.69 - $12.48 $225,940 - $324,480	-26,000 Reduced 60.05%	17,300 $154,000
Q3 2021 Nov 12, 2021	BUY	$8.43 - $16.81 $102,003 - $203,400	12,100 Added 38.78%	43,300 $553,000
Q2 2021 Aug 06, 2021	BUY	$9.85 - $16.46 $2,955 - $4,938	300 Added 0.97%	31,200 $496,000
Q1 2021 May 14, 2021	SELL	$12.71 - $24.31 $92,783 - $177,463	-7,300 Reduced 19.11%	30,900 $419,000
Q4 2020 Feb 12, 2021	BUY	$7.84 - $14.22 $66,640 - $120,870	8,500 Added 28.62%	38,200 $432,000
Q3 2020 Nov 13, 2020	BUY	$9.93 - $33.26 $128,097 - $429,054	12,900 Added 76.79%	29,700 $386,000
Q2 2020 Aug 13, 2020	BUY	$2.9 - $10.71 $48,720 - $179,928	16,800 New	16,800 $175,000

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

Black Rock Inc. New York, NY

5.32M
Shares

$38.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.98M
Shares

$35.9 Million
0.0% of portfolio
Ameriprise Financial Inc Minneapolis, MN

3.88M
Shares

$27.9 Million
0.01% of portfolio
State Street Corp Boston, MA

3.41M
Shares

$24.6 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.75M
Shares

$19.8 Million
1.44% of portfolio

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $353M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account